NCT05561972View on ClinicalTrials.gov

The Ultrasonographic Assessment of Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

February 15, 2022

Study Completion Date

March 15, 2022

Conditions
Genitourinary Syndrome of MenopauseSexual Function Disturbances
Interventions
DEVICE

injectable multifractional intercalated hyaluronic acid [Armonia®, Regenyal, Italy]

Armonia® 2 ml was injected into the vaginal wall with a standardized injection technique called Cannulated Intravaginal Injection Technique®. In this technique, Armonia® was injected as drops at 40 different points on the entire vaginal wall using 8 different entry points

Trial Locations (1)

34844

Maltepe University Faculty of Medicine, Istanbul

All Listed Sponsors
lead

Maltepe University

OTHER

NCT05561972 - The Ultrasonographic Assessment of Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter